Completed NCT01457235
This summary needs review. Please check the official study record and contact the research team for details.
In Copenhagen Why is this study shown? This study is directly about Bipolarity.
Bipolarity Behavioral From 18 Years to 50 Years
Countries Denmark
Sponsor Rigshospitalet, Denmark
Condition Bipolarity Completed NCT00154323
This study is completed. It is testing Oxcarbazepine 300-1200 mg/Day for Bipolarity.
Location not clearly listed Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug i A study involving a medication or substance. Over 18 Years
Countries
Sponsor Novartis
Condition Bipolarity Completed NCT01446406
This summary needs review. Please check the official study record and contact the research team for details.
In Copenhagen Why is this study shown? This study is directly about Bipolarity.
Bipolarity Behavioral From 18 Years to 60 Years
Countries Denmark
Sponsor Psychiatric Centre Rigshospitalet
Condition Bipolarity Completed NCT01575561
This study is completed in the United States, in France, in Argentina, .... It is testing lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for Bipolarity.
Multiple locations, including Dothan Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug Over 18 Years
Countries United States, France, Argentina, ...
Sponsor Sumitomo Pharma America, Inc.
Condition Bipolarity Terminated NCT03562520
This summary needs review. Please check the official study record and contact the research team for details.
In Toronto Why is this study shown? This study is directly about Bipolarity.
Bipolarity Behavioral From 13 Years to 21 Years
Countries Canada
Sponsor Sunnybrook Health Sciences Centre
Condition Bipolarity Completed NCT02970721
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 15 Years to 50 Years
Countries
Sponsor Western University, Canada
Condition Bipolarity Completed NCT01010204
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including DuBois Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States
Sponsor K.N. Roy Chengappa
Condition Bipolarity Completed NCT01293825
This summary needs review. Please check the official study record and contact the research team for details.
In Cleveland Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug Over 18 Years
Countries United States
Sponsor University Hospitals Cleveland Medical Center
Condition Bipolarity Completed NCT03259555
This study is completed in the United States, in Bulgaria, in Poland, .... It focuses on manic episodes in bipolarity type I.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries United States, Bulgaria, Poland, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity Terminated NCT00732251
This summary needs review. Please check the official study record and contact the research team for details.
In Los Angeles Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 70 Years
Countries United States
Sponsor Cedars-Sinai Medical Center
Condition Bipolarity Completed NCT00448578
This study is completed in China. It is testing seroquel and Lithium for manic episodes in bipolarity.
Multiple locations, including Beijing Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 65 Years
Countries China
Sponsor AstraZeneca
Condition Bipolarity Completed NCT00672490
This study is completed in China. It is testing Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania for manic episodes in bipolarity.
Multiple locations, including Beijing Why is this study shown? This study is directly about Bipolarity.
Bipolarity Drug From 18 Years to 60 Years
Countries China
Sponsor AstraZeneca
Condition Bipolarity